Keywords: Mylan, Antivirals, ARVs, India, NACO, Supply agreement

Mylan chosen to supply ARVs to India's national AIDS control body

Article | 04 September 2012

Leading USA-based generic drugmaker Mylan (Nasdaq: MYL) says that its India-based subsidiary Mylan Laboratories Limited has been selected as a ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Mylan Laboratories

Go to company listing